Literature DB >> 8470783

[General anesthesia in two patients with mitochondrial myopathy].

A Klockgether-Radke1, T Henze, U Braun, D Kettler.   

Abstract

Two patients with mitochondrial myopathy (Kearns-Sayre syndrome) received general anaesthesia. In the first case propofol-alfentanil anaesthesia was carried out; the second patient received propofol-fentanyl anaesthesia. Muscle relaxation was provided with vecuronium. In both cases we observed a short episode of bradycardia (heart rate < 50.min-1), which was successfully treated with atropine. After the propofol infusion had been stopped, both patients rapidly gained consciousness and were extubated after prompt spontaneous ventilation had returned. Reversal of neuromuscular blockade in the second patient was achieved within 5 min by neostigmine. Special anaesthetic problems in patients with mitochondrial myopathies such as myocardial conduction disturbances, postoperative muscle hypotonia, and possible increased susceptibility to malignant hyperthermia can be overcome by the described anaesthetic management.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8470783

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  3 in total

1.  Anesthetic management for an infant with mitochondrial cytopathy.

Authors:  Y Maegawa; H Nakagawa; T Hosokawa; Y Tanaka
Journal:  J Anesth       Date:  1995-12       Impact factor: 2.078

2.  General anesthesia for progressive external ophthalmoplegia syndrome.

Authors:  Kouichiro Minami; Takeyoshi Sata; Takao Takeda; Kenichiro Sagata; Koji Hara; Akio Shigematsu
Journal:  J Anesth       Date:  1995-09       Impact factor: 2.078

3.  Anesthetic management of a parturient with Kearns-Sayre syndrome, dual-chamber and VVI implantable defibrillator pacemaker/defibrillator, and preeclampsia for cesarean delivery: A case report and review of the literature.

Authors:  Abdulmohsen Al Ghamdi
Journal:  Saudi J Anaesth       Date:  2018 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.